Matthew Budoff MD Profile
Matthew Budoff MD

@BudoffMd

5,345
Followers
44
Following
16
Media
405
Statuses

Dr Budoff is a preventive cardiologist and Professor of Medicine at the David Geffen School of Medicine (UCLA) and principal investigator at Lundquist Institute

Torrance CA
Joined June 2020
Don't wanna be here? Send us removal request.
@BudoffMd
Matthew Budoff MD
1 year
Sad to report that a very physically active 66 year old patient with negative nuclear 2 years ago, taken off statin with 'clean bill of health', just passed away of SCD/MI with severe 3 VD. Wife had to do CPR. Wrong test, wrong answer. Need more CAC testing in asymptomatic pts
35
42
298
@BudoffMd
Matthew Budoff MD
6 months
This trial doesn't invalidate the lipid hypothesis, is not the final answer (Progression of soft plaque at 1 year is the final study) and is exactly as originally designed - see i have no skin in the game. i am just presenting our findings
25
31
224
@BudoffMd
Matthew Budoff MD
7 months
So Honored to have been awarded the physician if the year award by the California chapter of the ACC. So many great clinicians and researchers. Truly humbled. @ACCinTouch
25
15
203
@BudoffMd
Matthew Budoff MD
3 years
Evaporate Trial presented at #escprev2021 as late breaker, showing Icosapent Ethyl can reduce Lipid Rich Necrotic Core and intraplaque hemorrhage, while increasing fibrous cap thickness on CT angiography. Understanding the mechanism is so important. @DLBHATTMD @SuvasiniL
4
55
194
@BudoffMd
Matthew Budoff MD
1 year
Nothing lowers risk more than a CAC of zero. see data from MESA. #Powerofzero I trust it in all asymptomatic except the young (< 40 years of age) to derisk my patients, including DM and FH @khurramn1 @rblument1 @RonBlankstein
Tweet media one
14
38
194
@BudoffMd
Matthew Budoff MD
7 months
Very nice summary of some landmark articles in the world of coronary artery calcium in @rblument1
Tweet media one
1
44
180
@BudoffMd
Matthew Budoff MD
3 months
I still don't understand why colchicine continues to be disrespected - three positive outcome studies and CCTA plaque studies showing benefit, all for a 2a recommendation?
16
44
174
@BudoffMd
Matthew Budoff MD
2 months
Add another 54% of 11,805 patients from Denmark with LDL > 193 mg/dl also with normal CAC. NOT Everyone needs a statin, i hold therapy for CAC Zero unless DM, known ASCVD in this population with no CAC.
Tweet media one
@khurramn1
Khurram Nasir
3 months
61% Clinical FH patients with CAC Zero! Mean age 56 Loved the discussion #PowerOfZero getting more acceptance. #FactsAreFacts
Tweet media one
13
17
91
29
28
163
@BudoffMd
Matthew Budoff MD
3 years
Finally, CT angiography is the preferred test in US for a majority of patients with chest pain, following the UK (NICE) and ESC 2019 Guidelines. Great editorial by @RonBlankstein @DrMarthaGulati @lesleejshaw puts this in clinical perspective
@RonBlankstein
Ron Blankstein
3 years
Now out: The 2021 Multi Society Chest Pain Guideline A special thanks to the entire writing group led byย  @DrMarthaGulati and to the countless others who have worked on this over the past several years ๐Ÿ‘ @ACCinTouch @AHAScience & all partner societies ๐Ÿ‘‰
Tweet media one
7
122
339
4
56
159
@BudoffMd
Matthew Budoff MD
2 years
Great new study in NEJM Today - DISCHARGE Study, a large randomized trial confirms the CONSERVE Trial results that CTA is safer and results in similar outcomes as an invasive angiography first strategy. @NEJM @Heart_SCCT
3
31
134
@BudoffMd
Matthew Budoff MD
2 years
Great new paper in @JACCJournals showing CAC has highest AUC and best reclassification (especially downward - Power of Zero). @khurramn1 @RonBlankstein @MichaelJBlaha @rblument1
Tweet media one
3
35
121
@BudoffMd
Matthew Budoff MD
3 years
Yesterday marked another COVID Vaccine milestone - More Than 3.01 Billion Shots Given Globally. If there are any major health concerns, we would have seen it. The largest "N" of any study ever.
4
19
118
@BudoffMd
Matthew Budoff MD
1 year
A nice article demonstrating the harms of too much exercise. We have long seen the associated harms of marathon running on CAC and CV events, this article breaks it down between exercise volume and intensity. .
13
16
111
@BudoffMd
Matthew Budoff MD
1 year
Likely the best algorithm on when to incorporate CCTA in primary prevention, and then what to do with the results. #yesCCT @Heart_SCCT -Free article at @AJPC
Tweet media one
5
26
110
@BudoffMd
Matthew Budoff MD
3 years
You can't make an asymptomatic person feel better with a stent, so treat medically and if patient has breakthrough angina, can always stent the LAD
5
12
102
@BudoffMd
Matthew Budoff MD
2 years
We have great long term data from Walter Reed showing those persons with CAC=0 derive 0% benefit from 10+ years of statins. This is one of many such studies. Let's treat the disease, not everyone dies of CVD.
8
29
94
@BudoffMd
Matthew Budoff MD
2 months
Our new paper on colchicine and plaque just published
6
19
94
@BudoffMd
Matthew Budoff MD
9 months
A critically important study published today by Drs Maron and Rodrigues in @JACCJournals showing incidental CAC from ungated studies predict events and offer patients and clinicians a NO-COST opportunity to treat ASCVD. 2x risk of death with CAC > 100. RADIOLOGISTS - REPORT CAC
3
15
88
@BudoffMd
Matthew Budoff MD
11 months
See the updated "Calcium Club" meeting at ASPC, a group that dates back to the late 1990s promoting prevention through imaging @rblument1 @MichaelJBlaha @khurramn1 @Agatston_Center @RonBlankstein
Tweet media one
7
11
85
@BudoffMd
Matthew Budoff MD
2 years
Rita - Taylor and O'Malley did randomized studies with CAC specifically showing no increase in anxiety, depression or somatoform disorders using CAC, so your RCT is asked and answered. They also showed a 3.53 fold improvement in statin compliance over 4 years with CAC.
@RFRedberg
Rita Redberg
2 years
CAC scans offer no clinical benefits, often lead to more tests and worry, incidental findings and radiation risk. Need to rethink their use. Time for an RCT!
14
14
65
5
14
83
@BudoffMd
Matthew Budoff MD
2 years
The United States is now catching up to established medical pathways in Europe and the UK for years. CCTA has the best clinical, outcome and cost-effectiveness data of any diagnostic test in Cardiology. We need to continue to move towards the best algorithms for our patients
@RepTedLieu
Rep. Ted Lieu
2 years
Heart disease is the leading cause of death in the United States. That's why we led 14 Members in urging @CMSGov to cover the use of the cutting-edge CCTA test to detect coronary artery disease. Our letter #ICYMI :
Tweet media one
Tweet media two
Tweet media three
Tweet media four
18
43
141
5
19
82
@BudoffMd
Matthew Budoff MD
1 year
CT CAC data bests genetic factors for heart disease risk assessment Our JAMA paper today showed CAC score is more effective at predicting a person's risk for heart disease than polygenic risk scores. @AuntMinnie
7
28
79
@BudoffMd
Matthew Budoff MD
4 years
The presentation Late-Breaking Science in Lipids showing Icosapent Ethyl reduces plaque progression in EVAPORATE will be available on the On-Demand platform within 24 hours #ESCCongress 2020
5
24
76
@BudoffMd
Matthew Budoff MD
5 months
So excited to see our CONFIRM paper on CAC 300 and secondary prevention was the most talked about paper at JACC CI last year - and on the most read list -
3
13
76
@BudoffMd
Matthew Budoff MD
7 months
A reminder of power of CAC (and CCTA). Fuchs showed CAC Score of >300 associated risk of 7.05 for MI. Whether an 8-fold increased risk with obstructive-extensive disease by CCTA is superior to 7 fold increased risk with CAC needs exploration @khurramn1
2
18
71
@BudoffMd
Matthew Budoff MD
1 year
How far our society has fallen. Yesterday was the proclaimed "Day of Hate" where anti-semitic activities were being coordinated on a national level by neo-nazis. I spent my Saturday morning driving around my Temple to provide extra eyes and ears to the security guard we employ.
9
2
72
@BudoffMd
Matthew Budoff MD
4 years
Please join me at ESC this year to hear about results from icosapent ethyl in the EVAPORATE - FINAL. Free Registration for this virtual meeting. @the_lundquist @Heart_SCCT @ASPCardio
@DLBHATTMD
Dr. Deepak L. Bhatt
4 years
Just announced! EVAPORATE final results at ESC 2020 as a late-breaker presented by @BudoffMd - @SuvasiniL
1
24
80
0
16
71
@BudoffMd
Matthew Budoff MD
2 months
Great abstract at ACC, garnered a lot of press about post-menopausal women and CAC progression:
Tweet media one
6
14
73
@BudoffMd
Matthew Budoff MD
6 months
Please join me at the cedars advances in nuclear cardiology, cardiac ct, and mri meeting this January
Tweet media one
6
8
69
@BudoffMd
Matthew Budoff MD
1 year
Another great study demonstrating that rapid CAC progression is associated with all-cause mortality. If CAC is progressing, more needs to be done. This is not just 'statin' effect of increased density, rapid progression infers worsening atherosclerosis
3
24
68
@BudoffMd
Matthew Budoff MD
2 years
@ehj_ed @ESC_Journals So important to see these external validations of REDUCE-IT in clinical trials. As a preventive cardiologist, this is one of several very important tools in my toolbox, advocated by EVERY major society that looked at the data. Every group, except some rogue naysayers on twitter
1
24
67
@BudoffMd
Matthew Budoff MD
8 months
An excellent review of the power of zero and the low prevalence of non-calcified plaque when CAC = 0. by my former fellows - Irfan Zeb and Yasmin Hamirani
1
17
65
@BudoffMd
Matthew Budoff MD
1 year
Even more important that the primary prevention cohort saw a 32% event reduction. So unique in so many ways. First study in statin intolerant, first with 48% women, first to show non-statin benefit in primary prevention.
@Drlipid
Thomas Dayspring
1 year
CLEAR Outcomes trial presented & published today- Bempedoic acid moves to the big league of proven LDL lowering (via LDLR clearance of apoB-LP drugs). Amazing results considering the drop in lipid Rx in placebo group. @society_eas @nationallipid
Tweet media one
Tweet media two
Tweet media three
Tweet media four
4
19
112
4
13
65
@BudoffMd
Matthew Budoff MD
8 months
We are delighted to announce the online publication of our research paper (open access), which explores the combination of computed tomography angiography with coronary artery calcium scoring to improve the diagnosis of coronary artery disease.
3
15
62
@BudoffMd
Matthew Budoff MD
1 year
Our analysis of the RESPECT Trial (EPA and outcomes, AHA 2022) is now published
0
17
60
@BudoffMd
Matthew Budoff MD
2 years
Congrats to Corcal study in @JACCJournals (CI) - The investigators concluded that CAC guidance may be a more efficient, personalized, cost-effective, and motivating approach to statin initiation and maintenance in primary prevention.
4
12
60
@BudoffMd
Matthew Budoff MD
2 years
Thanks to all my co-authors that each contributed, and especially to @ASPCardio and President Peter Toth for helping shepherd this important paper through. @SuvasiniL @ErinMichos @khurramn1 @AChoiHeart @ChinnaiyanMD @MichaelJBlaha
@ErinMichos
Erin D. Michos, M.D.
2 years
#YesCCT ! Check out this @ASPCardio Practice Statement led by @BudoffMd , written with all-star team of authors, about the use Cardiac CT Angiography in Current Practice & Implications for CVD Prevention. The intersection of #cvImaging & #cvPrev . @AJPCardio
Tweet media one
4
32
109
2
14
60
@BudoffMd
Matthew Budoff MD
5 months
So proud to be associated with this study as the imaging core lab director. Will have great data emerging about this at risk population
@nih_nhlbi
NIH NHLBI
5 months
Check out our feature story on the RURAL Cohort Study, a long-term research project aimed at assessing the health of residents in the rural South. The study uses a high-tech research clinic on wheels that travels throughout the region. Read here:
Tweet media one
0
5
12
0
6
58
@BudoffMd
Matthew Budoff MD
2 years
And we have 7 (yes 7) prospective trials showing EPA slows or reverses atherosclerosis by QCA, IVUS, OCT, and CCTA, including CHERRY and EVAPORATE Trials. 10 trials is enough. EPA lowers events and slows atherosclerosis.
@cpcannon
Christopher Cannon, M.D. ๐Ÿ‡บ๐Ÿ‡ฆ
2 years
Itโ€™s the EPAโ€ฆ. A third trial showing benefit with EPA! (The original JELIS, then REDUCE-IT, and now RESPECT EPA).
0
4
28
1
17
58
@BudoffMd
Matthew Budoff MD
2 years
Except for the fact that the warranty of a normal CCTA is probably 7-10 years (not 2 years) and the use of CCTA is preferred in men to age 70 (median cac 211) and women up to at least age 75 (median cac 67), this certainly represents a move in the right direction.
@journalCCT
Journal of Cardiovascular CT
2 years
Check out this review article of the new chest pain guidelines The 99 page document is distilled into 10 key messages for #YesCCT use @CardiacCTGuy @AChoiHeart @DrKelleyBranch @armin_zadeh @RonBlankstein @lesleejshaw @ToddVillinesMD
Tweet media one
2
31
50
3
14
57
@BudoffMd
Matthew Budoff MD
5 months
And our paper on Major Global Coronary Calcium Guidelines also made the most read list:
2
8
56
@BudoffMd
Matthew Budoff MD
10 months
See how CAC outperforms ABI in this MESA study.
2
9
56
@BudoffMd
Matthew Budoff MD
1 month
a new study last month in @JACCJournals about the validation of Cleerly's AI-guided coronary CT angiography technology, Enabling a one-stop comprehensive analysis of plaque, stenosis and ischemia detection in a single exam.
2
15
58
@BudoffMd
Matthew Budoff MD
4 years
I pray that FDA follows suit and approves a vaccine. 1500 Americans die every day of Covid. the vaccine has the potential to reduce that, and every day the FDA delays, another 1500 americans die. We can do postmarketing surveillance and see how we all do with the vaccine
3
2
49
@BudoffMd
Matthew Budoff MD
1 year
As we continue to learn, the presence of CAC with elevated LDL is the most robust predictor of whom is at risk of 'high' LDL. Not everyone develops ASCVD from high lipids, just like all women do not develop breast cancer.
Tweet media one
@Drlipid
Thomas Dayspring
1 year
Paraphrasing @MichaelDavidson (1) Aggressive Rx of apoB early in life is the key (2) Not a fan of current "10 yr risk-based" analysis - (3) need to relate apoB (LDL) to time (4) Polygenetic risk score is emerging & lipids relate more to genes than diet.
3
10
43
2
10
49
@BudoffMd
Matthew Budoff MD
6 months
@DrNadolsky Spencer - not sure why you are making false claims on X. We did not exclude anyone with plaque, this is just blatantly false. The ONLY study we ever planned was plaque progression, and the trial is ongoing - results pending early 2024. I presented baseline data only so far.
7
4
48
@BudoffMd
Matthew Budoff MD
2 years
Important study, reminding us that we see the aortic calcifications on PE studies, abdominal CT and lung cancer screening studies and can institute good therapy. Chris's approach to look back at old scans is a model we should all follow when we see new patients for prevention.
@cpcannon
Christopher Cannon, M.D. ๐Ÿ‡บ๐Ÿ‡ฆ
2 years
For risk stratification, I look in patient's charts for old CT scans, and if I find atherosclerosis - I treat to ASCVD target of LDL < 70 mg/dl. This trial shows the risk of abdominal Atherosclerosis matches that of CAC score.
13
48
197
2
10
49
@BudoffMd
Matthew Budoff MD
1 month
Great article covering potential of aspirin use in high Lp(a). Maybe something we can do for our patients while we wait for specific therapies
4
8
49
@BudoffMd
Matthew Budoff MD
4 years
Became part of the solution yesterday. Enrolled in the Oxford Vaccine trial. I believe in vaccines, I believe in clinical trials, so I participated. @the_lundquist
1
6
49
@BudoffMd
Matthew Budoff MD
2 years
An area we are actively studying with serial CCTA in a prospective trial. Ketogenic diets with pronounced LDL responses. See this manuscript just published:
3
2
46
@BudoffMd
Matthew Budoff MD
4 months
So important to understand the benefits of EPA, as compared to EPA/DHA. Not sure why many of my colleagues don't get it, but this is another important paper demonstrating that benefit.
@DLBHATTMD
Dr. Deepak L. Bhatt
4 months
Do patients benefit from omega-3 fatty acids? #cardiology #cardiotwitter #prevention @gabrielsteg
8
31
83
2
13
47
@BudoffMd
Matthew Budoff MD
3 years
Inspired by the actions of my fellow health care professionals who saved a life last night at the Hollywood Bowl. Stepped up, did bystander CPR and saved a young woman's life, despite any unknown COVID risks.
2
0
48
@BudoffMd
Matthew Budoff MD
2 years
So important to remember the Power of Zero, a population based study showing extremely low risk in patients with CAC zero. What we have been saying all along. @rblument1 @RonBlankstein @ErinMichos
@khurramn1
Khurram Nasir
2 years
#1 Dreams do come true, needed a spark in 2014, health system @BaptistHealthSF inspired to make difference, bold leadership ( @JackZiffer @DrBTKatzen @Calvinchb @drjbone1 & others), generous community coming together #MiamiHeartStudy to realize the first fruit of these efforts๐Ÿ‘‡
Tweet media one
Tweet media two
33
48
207
0
7
47
@BudoffMd
Matthew Budoff MD
3 years
So important to recognize that CAC and CCT are critical evaluations for women as well as men. No difference in false positives as seen with nuclear. Glad to see @ACCinTouch promoting this use (finally).
@SuvasiniL
Suvasini Lakshmanan
3 years
2
7
18
0
13
46
@BudoffMd
Matthew Budoff MD
4 years
Missed the EVAPORATE Presentation (as it was live at 3 AM EST) Saturday morning? find it here: View on demand @escardio Thanks for all the support.
4
17
45
@BudoffMd
Matthew Budoff MD
10 months
Great article by @JairoaldanaMD on ccta regression studies.
1
17
46
@BudoffMd
Matthew Budoff MD
2 years
Just Published @ASPCardio CAC Practice statement (open access): @ErinMichos @DrNathanWong @kcferdmd @DrMichaelShapir
3
13
45
@BudoffMd
Matthew Budoff MD
1 year
An important new paper from our bone density research showing the relationships between bone density and CAC in MESA.
4
8
45
@BudoffMd
Matthew Budoff MD
2 years
An important paper, CAD RADS 2, so proud to be among the writing group lead by @cury_ricardo and @RonBlankstein , @Heart_SCCT , can download for free here:
2
11
44
@BudoffMd
Matthew Budoff MD
2 years
Great talk on fish oils and outcomes, including the mineral oil issue, at ISC 2022 @AHAMeetings , @American_Stroke , with Mark Alberts, Lawrence Leiter. Builds on work from @SuvasiniL @DLBHATTMD and so comprehensive, worth a view.
3
7
43
@BudoffMd
Matthew Budoff MD
2 years
Every paper since Steve Haffner's original paper have suggested diabetes is about 50% the risk of prior MI. CAC > 300 is similar to prior MI, new data coming out, so if you want CVD risk equivalent, get a CAC scan, with or without DM.
@khurramn1
Khurram Nasir
2 years
@drpablocorral Thankfully we are overcoming dogmatic belief for so many years DM CVD equivalent๐Ÿ‘
0
0
8
2
10
42
@BudoffMd
Matthew Budoff MD
2 years
So happy to be walking the halls of AHA and seeing so many giants of cardiology in one place. Inspiring. Bob Eckel, Carl Pepine, Roger Blumenthal, Bob Rosenson, Steve N, keith Ferdinand, the list goes on. Live meetings are critical to advance science
0
4
43
@BudoffMd
Matthew Budoff MD
1 year
I believe the EVAPORATE Trial approach will become a standard approach, measuring plaque burden AND physiology with #FFRCT #YesCCT
@MGRabbatMD
Mark Rabbat MD
1 year
My thoughts on our publication demonstrating improvement in coronary physiology with icosapent ethyl using #FFRCT . Our study is the first to suggest #FFRCT can be a way to assess the effect of cardiovascular drugs. @DLBHATTMD @BudoffMd @CardiologyToday #YesCCT @Heart_SCCT
1
6
25
1
7
42
@BudoffMd
Matthew Budoff MD
2 years
David - that is just not true. Eisner was not an outcome study, it showed CAC improved compliance, lowered blood pressure, cholesterol and weight. it was not powered, and did not show, any significant outcome difference as it was 2,137 patients randomized to cac/no-cac.
@DavidLBrownMD
Less-Is-More Cardiologist
2 years
@RFRedberg You mean another RCT. EISNER showed no benefit (in fact, an increase in death/MI) from calcium scanning.
1
0
5
3
4
39
@BudoffMd
Matthew Budoff MD
8 months
Such an important paper showing increased CAC slope the steepest among SA, correlating with the high risk of DM and CVD in this population.
@JamalRanaMD
Jamal Rana, MD
8 months
Our much awaited paper from #MESA & #MASALA โค๏ธ. Diabetes โฌ†๏ธ likelihood CAC in #SouthAsians (SA) & Whites. Clinically significant > 100 CAC in SA & Chinese. โฌ†๏ธ fasting glucose โฌ†๏ธCAC in SA. Led by Dr. Premyodhin. @DrNathanWong @BudoffMd @alka_kanaya
Tweet media one
Tweet media two
Tweet media three
Tweet media four
8
36
114
1
15
41
@BudoffMd
Matthew Budoff MD
1 year
Statin intolerance in CLEAR OUTCOMES required this form to be signed by both patient and physician #CardsJC
Tweet media one
1
5
41
@BudoffMd
Matthew Budoff MD
4 years
Time to move beyond functional testing. Referrals leading to only 45% prevalence of obstructive disease in the cath lab is not acceptable anymore.
@LairdLi_PA
Lisa Laird
4 years
Data from 385,000 - functional testing suboptimal #CVD #HID2020 Matthew J Budoff MD
Tweet media one
0
0
7
1
9
39
@BudoffMd
Matthew Budoff MD
1 year
On a positive note, I am very excited about going back live to American College of Cardiology in New Orleans next week. Hope to see many friends and colleagues. #ACC23 / #WCCardio
2
1
40
@BudoffMd
Matthew Budoff MD
9 months
This is the article on incidental CAC and outcomes:
4
10
39
@BudoffMd
Matthew Budoff MD
2 years
So pleased that our Primer on CT imaging in Cardio-Onc is finally out - thanks to all co-authors @onco_cardiology @datsunian @CardiacCTGuy @CardioOnc_MR_CT and special thanks to editors at @JACCCardioOnc
4
16
40
@BudoffMd
Matthew Budoff MD
4 years
Wanted to wish everyone a wonderful Thanksgiving. I am thankful for the incredible science that moved vaccines at (dare I say) warp speed. I am in the Oxford trial, Pfizer and Moderna look even better. Let's hope FDA can approve these and get us all back together soon - ACC2021
0
1
38
@BudoffMd
Matthew Budoff MD
2 years
Congratulations, a well deserved recipient who has championed CAC testing and validated Power of Zero among many other important concepts with CAC, including leading the Calcium Consortium
@Heart_SCCT
Heart_SCCT
2 years
Congratulations to the 2022 Agatston Award recipient @MichaelJBlaha This award recognizes individuals whose pioneering efforts have saved lives from the leading killer throughout the world, coronary artery disease. @HopkinsMedicine @CiccaroneCenter @hopkinsheart
Tweet media one
17
21
148
0
5
39
@BudoffMd
Matthew Budoff MD
7 months
Very excited to again be part of the Advances in Nuclear Cardiology, Cardiac CT and Cardiac MRI: 37th Annual Case Review with the Experts this January at Cedars Sinai in Los Angeles.
0
3
39
@BudoffMd
Matthew Budoff MD
2 years
So important to acknowledge AHA as recognizing that High value health care = CAC in intermediate risk patients (and low-intermediate risk patients). Need to keep moving the needle. @ASPCardio @American_Heart @DrMarthaGulati @ErinMichos @DrNathanWong
@khurramn1
Khurram Nasir
2 years
@pnatarajanmd @American_Heart @NEJM @CircOutcomes @vinaykiniMD @bnallamo @TYWangMD @KBreathettMD @wbborden Cac as high value test in intermediate risk patients!! Wow.. time has really changed something never imagined we will see these statements 5-10 yrs ago Kudos @MichaelJBlaha @BudoffMd @RonBlankstein @rblument1 @miguelcainzos23 and others getting to close this evidence gaps ๐Ÿ‘๐Ÿ‘
3
7
30
4
10
39
@BudoffMd
Matthew Budoff MD
1 year
Nice Review of CCTA for acute chest pain, jby Suraj Dahal, a Class IA indication with 7 prospective trials showing superiority over nuclear, hs troponins, treadmill, standard of care and CCTA still comes out faster, less expensive and superior.
3
11
39
@BudoffMd
Matthew Budoff MD
2 years
After the ACC/AHA Chest Pain guidelines badly botched the warranty issue with CCTA, we present the data on long term safety of a normal CCTA @journalCCT
2
6
38
@BudoffMd
Matthew Budoff MD
3 years
Proud to be participating in a multi-modality diabetes treatment algorithm #DCRMDallasWorkshop , with many incredible collaborators @CBallantyneMD @ErinMichos @yhandelsmanmd @MkosiborodMD @DLBHATTMD @BiykemB among many, many others
0
4
38
@BudoffMd
Matthew Budoff MD
4 years
A9. Yes, the St Francis Heart study showed that treating high CAC (>75th percentile) with atorvastatin 20 mg in a randomized trial lowers events by 30%, and those with CAC >400 by 42%. #NLATwitterChat #NLACAC
3
11
38
@BudoffMd
Matthew Budoff MD
3 years
Big believer in CAC for diabetes, especially younger patients were guidelines are not so strong. Not all persons with diabetes have the same CV risk. CAC can help.
@khurramn1
Khurram Nasir
4 years
@VietHeartPA @APAC_Cardiology I hope the next guidelines can update Yes cac for diabetes... so much value in guiding intensity and choices on treatment All diabetics are not the same @BudoffMd @MichaelJBlaha @RonBlankstein @miguelcainzos23 @rblument1
1
0
13
0
11
38
@BudoffMd
Matthew Budoff MD
3 years
There are still a few anti-statin and anti-CAC physicians out there, unfortunately, the editor of JAMA IM is one of them. Sad when we are there are those advocating AGAINST the guidelines and using positions of power to misinform clinicians. 30 years of science behind CAC.
@khurramn1
Khurram Nasir
3 years
@dmljmd @MichaelJBlaha @ErinMichos @DrMarthaGulati @braun_lynne @nstonedoc @rblument1 @JAMAInternalMed @ACCinTouch @AHAScience @ASPCardio @Heart_SCCT #1A reg CAC while we truly encourage discourse on its utility in clinical practice but truly saddening to see blatant misinformation propagated by @JAMAInternalMed @MInczeMD "risk calculators more accurate than CAC" Facts established by many NHLBI & international cohorts๐Ÿ‘‡
Tweet media one
Tweet media two
Tweet media three
Tweet media four
1
9
30
0
7
36